Center for Drug Evaluation & Research Director Janet Woodcock believes that the US FDA has figured out how to get guidances out much more rapidly, touting a “just-say-it” approach that focuses on bullet points and key messages rather than longer, discursive text. (Also see "'Just Say It!' – New Streamlined Guidance Format Coming, FDA's Woodcock Says" - Pink Sheet, 14 November, 2017.)
During the recent Food & Drug Law Institute annual meeting, in fact, Woodcock responded to a question about what is...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?